Detail akcie Kamada Ltd online

Business Summary: Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Kamada Ltd revenues increased 11% to $135.8M. Net income increased 56% to $16.6M. Revenues reflect Proprietary Products segment increase of 7% to $118M, Distribution segment increase of 49% to $17.8M, Latin America segment increase from $7.6M to $16.3M, Israel segment increase of 36% to $22.6M. Net income benefited from Research and Development Expenses decrease of 19% to $10.1M (expense).